Article
Molecular profiling and access to treatment for rare cancers in Europe.
Nature communications - 23 Jul 2026
Morfouace M, Hoogstoel F, Oliveira J, Penel N, Tejpar S, Ray-Coquard I, Peron J, Pracht M, Brasiuniene B, Capela A, Gennigens C, Greillier L, Even C, Huang R, Gorlia T, Lombardi G, Gamulin M, Licitra L, Girard N, Klümpen H J, Idbaih A, Van der Graaf Wta, Blay J Y
Abstract excerpt
Arcagen is a clinical study proposing a comprehensive analysis of molecular and clinical characteristics of rare adult solid cancers (11 domains: sarcomas, gynecology, uro-genital, GI, NET, head and neck, thoracic, skin and eyes, CNS and CUP) across Europe, utilizing the EORTC-SPECTA platform with the EURACAN ERN. This study enrolled 1235 advanced stage patients. 893 were evaluable for molecular profiling toward...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.